Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the <scp>GLORIA</scp> ‐ <scp>AF</scp> registry phase <scp>III</scp>

DM was independently associated with higher risks of all-cause death, CV death, MI, major bleeding and MACE in AF individuals. Individuals receiving insulin alone were associated with higher risks of all-cause death, CV death, MI, major bleeding and MACE.